Key result
Pacemaker therapy in familial amyloidosis with polyneuropathy resulted in a mean stimulation threshold of 1.0 V at implantation and 1.9 V at 6 months, with no high threshold exit block occurring.
Why the study?
What are the cardiac stimulation thresholds and risk of exit block in patients with familial amyloidosis with polyneuropathy receiving pacemaker therapy?
Observational (n=14)
What are the cardiac stimulation thresholds and risk of exit block in patients with familial amyloidosis with polyneuropathy receiving pacemaker therapy?
Pacemaker therapy is feasible in patients with familial amyloidosis with polyneuropathy without high threshold exit block, though a multiprogrammable pulse generator with high output capability is recommended.
Answers are grounded in this paper and cite their sources.
Pacemaker therapy may be feasible without exit block in this case; leaves open broader applicability in familial amyloidosis with polyneuropathy.
It has been suggested that a higher cardiac stimulation threshold reduces the applicability of pacemaker therapy in cardiac amyloidosis. We therefore reviewed threshold data in patients with familial amyloidosis with polyneuropathy (FAP), which is an inherited type of systemic amyloidosis, invariably involving the heart. Fourteen FAP patients treated with a pacemaker were studied. The mean (+/- SD) voltage stimulation threshold during implantation was 1.0 +/- 0.5 V, and noninvasive follow-up 6 months later revealed a mean Vario threshold of 1.9 +/- 0.5 V. Beyond this time, the threshold tended to be stable, and high threshold exit block did not occur in any patient. Several FAP patients did show a moderately elevated threshold, and a multiprogrammable pulse generator with a high output capability is recommended when pacemaker therapy is considered in these patients.
No takes yet. Share an insight, caveat, or question.
Jansson et al. (1987) conducted an observational in Familial amyloidosis with polyneuropathy (n=14). Pacemaker therapy was evaluated on Voltage stimulation threshold. Pacemaker therapy in familial amyloidosis with polyneuropathy resulted in a mean stimulation threshold of 1.0 V at implantation and 1.9 V at 6 months, with no high threshold exit block occurring.
Synapse has enriched 10 related papers. Consider them for comparative context: